Nanodesigning of multifunctional quantum dots and nanoparticles for the treatment of fibrosarcoma

References

• Adjei, I.M., Sharma, B., and Labhasetwar, V., 2014. Nanoparticles: cellular uptake and cell viability. Advances in experimental medicine and biology, 811, 73–91.
   PubMed Web of Science ®Google Scholar
• Arriagada, F., et al., 2019. Development and characterization of florfenicol-loaded BSA nanoparticles as controlled release carrier. AAPS PharmSciTech, 20 (5), 202.
   PubMed Web of Science ®Google Scholar
• Artursson, P., and Karlsson, J., 1991. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochemical and biophysical research communications, 175 (3), 880–885.
   PubMed Web of Science ®Google Scholar
• Avgoustakis, K., et al., 2002. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. Journal of controlled release, 79 (1–3), 123–135.
   PubMed Web of Science ®Google Scholar
• Bajwa, N., et al., 2016. Pharmaceutical and biomedical applications of quantum dots. Artificial cells, nanomedicine, and biotechnology, 44, 758–768.
   PubMed Web of Science ®Google Scholar
• Barbanoj, M.J., Antonijoan, R.M., and Gich, I., 2001. Clinical pharmacokinetics of dexketoprofen. Clinical pharmacokinetics, 40 (4), 245–262.
   PubMed Web of Science ®Google Scholar
• Barenholz, Y., 2012. Doxil®-the first FDA-approved nano-drug: lessons learned. Journal of controlled release, 160 (2), 117–134.
   PubMed Web of Science ®Google Scholar
• Behzadi, E., et al., 2017. Macrophage cell-derived exosomes/staphylococcal enterotoxin B against fibrosarcoma tumor. Microbial pathogenesis, 111, 132–138.
   PubMed Web of Science ®Google Scholar
• Bende, G., et al., 2008. UV-spectrophotometric determination of imatinib mesylate and its application in solubility studies. Pharmazie, 63, 641–645.
   PubMedGoogle Scholar
• Beretta, G.L., et al., 2017. Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents. European journal of medicinal chemistry, 142, 271–289.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya, G.S., 2010. Oral systemic therapy: Not all "win-win". Indian journal of medical and paediatric oncology, 31 (1), 1–3.
   PubMedGoogle Scholar
• Bhise, K.S., et al., 2007. Effect of oppositely charged polymer and dissolution medium on swelling, erosion, and drug release from chitosan matrices. AAPS PharmSciTech, 8 (2), 44.
   Google Scholar
• Birhanu, G., et al., 2017. Nanotechnology for delivery of gemcitabine to treat pancreatic cancer. biomedecine & pharmacotherapie [Biomedicine & pharmacotherapy], 88, 635–643.
   PubMed Web of Science ®Google Scholar
• Boulenc, X., et al., 1993. Importance of the paracellular pathway for the transport of a new bisphosphonate using the human CACO-2 monolayers model. Biochemical pharmacology, 46 (9), 1591–1600.
   PubMed Web of Science ®Google Scholar
• Cai, X., et al., 2016. pH-sensitive ZnO quantum dots-doxorubicin nanoparticles for lung cancer targeted drug delivery. ACS applied materials & interfaces, 8 (34), 22442–22450.
   PubMed Web of Science ®Google Scholar
• Chen, Q., et al., 2015. The importance of Src signaling in sarcoma. Oncology letters, 10 (1), 17–22.
   PubMedGoogle Scholar
• Demir, G.M., and Deǧim, I.T., 2018. Determination of imatinib mesylate and erlotinib hydrochloride in mice plasma using ultrahigh performance liquid chromatography method. Kuwait journal of science, 45, 57–63.
   Google Scholar
• Demirbolat, G.M., et al., 2018. Development of orally applicable, combinatorial drug-loaded nanoparticles for the treatment of fibrosarcoma. Journal of pharmaceutical sciences, 107 (5), 1398–1407.
   PubMedGoogle Scholar
• Din, F.U., et al., 2017. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. International journal of nanomedicine, 12, 7291–7309.
   PubMedGoogle Scholar
• Erdogan, O., et al., 2019. Green synthesis, characterization, anti-bacterial and cytotoxic effects of zinc oxide nanoparticles using aqueous extract of artichoke leafs. Duzce medical journal, 21, 19–26.
   Google Scholar
• Esim, O., et al., 2017. Development of assay for determination of eletriptan hydrobromide in loaded PLGA nanoparticles. Journal of pharmaceutical and biomedical analysis., 142, 74–83.
   PubMedGoogle Scholar
• Fletcher, K., 2006. Soft tissue tumors: epidemiology, clinical features, histopathological typing and grading. Pathology and genentics tumors soft tissue bone, 1, 12–18.
   Google Scholar
• Foroozandeh, P., and Aziz, A.A., 2018. Insight into cellular uptake and intracellular trafficking of nanoparticles. Nanoscale research letters, 13 (1), 339.
   PubMed Web of Science ®Google Scholar
• Gao, Y., et al., 2014 Jul-Aug. Nanotechnology-based intelligent drug design for cancer metastasis treatment. Biotechnology advances, 32 (4), 761–777.
   PubMed Web of Science ®Google Scholar
• Gutha, Y., et al., 2017. Antibacterial and wound healing properties of chitosan/poly(vinyl alcohol)/zinc oxide beads (CS/PVA/ZnO). International journal of biological macromolecules, 103, 234–241.
   PubMed Web of Science ®Google Scholar
• Guven, A., et al., 2017. Carbon nanotube capsules enhance the in vivo efficacy of cisplatin. Acta biomaterialia, 58, 466–478.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., and Weinberg, R.A., 2011. Hallmarks of cancer: the next generation. Cell, 144 (5), 646–674.
   PubMed Web of Science ®Google Scholar
• Ho, V. W. T., Tan, H. Y., and Wang, N., 2019. Cancer management by tyrosine kinase inhibitors: efficacy, limitation, and future strategies, Ren H., tyrosine kinases as druggable targets cancer. Rijeka: IntechOpen.
   Google Scholar
• Iqbal, N., and Iqbal, N., 2014. Imatinib: a breakthrough of targeted therapy in cancer. Chemotherapy research and practice, 2014, 357027–357029.
   PubMedGoogle Scholar
• Jahangir, M.A., et al., 2019. Quantum dots: next generation of smart nano-systems. Pharmaceutical nanotechnology, 7 (3), 234–245.
   PubMedGoogle Scholar
• Janes, K.A., et al., 2001. Chitosan nanoparticles as delivery systems for doxorubicin. Journal of controlled release, 73 (2–3), 255–267.
   PubMedGoogle Scholar
• Khodabandehloo, H., Zahednasab, H., and Ashrafi Hafez, A., 2016. Nanocarriers usage for drug delivery in cancer therapy. Iranian journal of cancer prevention, 9 (2), e3966.
   PubMedGoogle Scholar
• Kim, H.B., et al., 2020. Electrohydrodynamically atomized pH-responsive PLGA/ZnO quantum dots for local delivery in lung cancer. Macromolecular research, 28 (4), 407–414.
   Google Scholar
• Lei, G., et al., 2020. In Situ preparation of amphibious ZnO quantum dots with blue fluorescence based on hyperbranched polymers and their application in bio-imaging. Polymers, 12 (1), 144.
   Google Scholar
• Li, S.-D., and Huang, L., 2009. Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. Biochimica et biophysica acta, 1788 (10), 2259–2266.
   PubMed Web of Science ®Google Scholar
• Liu, B., et al., 2019. Semiconductor quantum dots in tumor research. Journal of luminescense., 209, 61–68.
   Web of Science ®Google Scholar
• Lv, Y., et al., 2013. Controllable synthesis of ZnO nanoparticles with high intensity visible photoemission and investigation of its mechanism. Nanotechnology, 24 (17), 175702.
   PubMedGoogle Scholar
• Mirnajafizadeh, F., et al., 2019. Stride, nanoparticles for bioapplications: study of the cell viability of water dispersible CdSe(S) and CdSe(S)/ZnO quantum dots. Nanomaterials, 9 (3), 465.
   Google Scholar
• Mirza, A.Z., and Siddiqui, F.A., 2014. Nanomedicine and drug delivery: a mini review. International nano letters, 4 (94).
   Google Scholar
• Nottingham, E., et al., 2020. The role of self nano emulsifying drug delivery systems of CDODA-Me in sensitizing erlotinib resistant nonsmall cell lung cancer. Journal of pharmaceutical sciences., 109 (6), 1867–1882.
   PubMed Web of Science ®Google Scholar
• Noyes, A.A., and Whitney, W.R., 1897. The rate of solution of solid substances in their own solutions. Journal of the American Chemical Society, 19 (12), 930–934.
   Google Scholar
• Probst, C.E., et al., 2013. Quantum dots as a platform for nanoparticle drug delivery vehicle design. Advanced drug delivery reviews, 65 (5), 703–718.
   PubMed Web of Science ®Google Scholar
• Pyne, J., Sapkota, D., and Wong, J.C., 2012. Squamous cell carcinoma: variation in dermatoscopic vascular features between well and non-well differentiated tumors. Dermatology Practical & Conceptual, 2, 204a05–204a05.
   PubMedGoogle Scholar
• Risbud, M.V., et al., 2000. pH-sensitive freeze-dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. Journal of controlled release, 68 (1), 23–30.
   PubMed Web of Science ®Google Scholar
• Sheng, F., et al., 2020. Preparation of quercetin nanorod/microcrystalline cellulose formulation via fluid bed coating crystallization for dissolution enhancement. International journal of pharmaceutics, 576, 118983.
   PubMedGoogle Scholar
• Shi, J., et al., 2010. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano letters, 10 (9), 3223–3230.
   PubMedGoogle Scholar
• Unagolla, J.M., and Jayasuriya, A.C., 2018. Drug transport mechanisms and in vitro release kinetics of vancomycin encapsulated chitosan-alginate polyelectrolyte microparticles as a controlled drug delivery system. European journal of pharmaceutical science, 114, 199–209.
   PubMed Web of Science ®Google Scholar
• van Breemen, R.B., and Li, Y., 2005. Caco-2 cell permeability assays to measure drug absorption. Expert opinion on drug metabolism & toxicology, 1 (2), 175–185.
   PubMedGoogle Scholar
• Wu, C., et al., 2020. Intranasal delivery of paeoniflorin nanocrystals for brain targeting. Asian journal of pharmaceutical sciences, 15 (3), 326–335.
   PubMed Web of Science ®Google Scholar
• Xu, Y., and Du, Y., 2003. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. International journal of pharmaceutics, 250 (1), 215–226.
   PubMed Web of Science ®Google Scholar
• Yalcin, T.E., Ilbasmis-Tamer, S., and Takka, S., 2018. Development and characterization of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs) using central composite design. International journal of pharmaceutics, 548 (1), 255–262.
   PubMedGoogle Scholar
• Yu, W., et al., 2020. Size-tunable strategies for a tumor targeted drug delivery system. ACS central science, 6 (2), 100–116.
   PubMed Web of Science ®Google Scholar
• Yuan, Q., Hein, S., and Misra, R.D.K., 2010. New generation of chitosan-encapsulated ZnO quantum dots loaded with drug: Synthesis, characterization and in vitro drug delivery response. Acta biomaterialia, 6 (7), 2732–2739.
   PubMed Web of Science ®Google Scholar
• Yücel, C., Değim, Z., and Yilmaz, S., 2013. Nanoparticle and liposome formulations of doxycycline: transport properties through Caco-2 cell line and effects on matrix metalloproteinase secretion. biomedecine & pharmacotherapie [Biomedicine & pharmacotherapy], 67 (6), 459–469.
   PubMedGoogle Scholar
• Yucel, C., et al., 2019. Novel approach to the treatment of diabetes: embryonic stem cell and insulin-loaded liposomes and nanocochleates. Journal of nanoscience and nanotechnology., 19, 3706–3719.
   PubMedGoogle Scholar
• Zhu, D., et al., 2017. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma. Acta biomaterialia, 58, 399–412.
   PubMed Web of Science ®Google Scholar
• Zielichowska, A., et al., 2016. Applications of calcium electroporation to effective apoptosis induction in fibrosarcoma cells and stimulation of normal muscle cells. Bioelectrochemistry, 109, 70–78.
   PubMedGoogle Scholar